DR Reddys Laboratories (RDY) financials
- Mar 2025
Price
Performance −11.2% 1Y
1Y: $14.87 on 22 Oct 2025 → $13.21. High $15.38 (26 Jun 2026), low $11.38 (22 Jul 2026).
- Previous close
- $13.23
- 52-week range
- $11.38 – $15.38
- One year
- −9.64%
Overview
- Symbol
- RDY
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- US
- Currency
- USD
Financials
What the filings say
| Line item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total liabilities | 1,523 | 1,232 | 1,025 | 1,264 | 1,348 | 1,106 | 1,284 | 1,825 |
| Fixed assets | 889 | 782 | 694 | 781 | 819 | 809 | 923 | 1,144 |
| Total assets | 3,465 | 3,259 | 3,081 | 3,630 | 3,860 | 3,916 | 4,650 | 5,772 |
| Line item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 277 | 415 | 396 | 488 | 370 | 716 | 545 | 545 |
| Cash from investing | -229 | -112 | -65 | -310 | -348 | -503 | -483 | -682 |
| Cash from financing | -68 | -308 | -334 | -4 | -32 | -327 | -45 | 222 |
| Capital expenditure | -143 | -101 | -64 | -133 | -193 | -138 | -197 | -322 |
| Free cash flow | 134 | 314 | 332 | 355 | 177 | 578 | 348 | 223 |
Insider filings
No filings in the last 12 months.
No officer, director or 10% owner of RDY filed a Form 4 in this window. That is a statement about filings, not about ownership — see the note below.
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for DR REDDYS LABORATORIES LTD
Free account. Everything above stays public.
Write why you follow DR REDDYS LABORATORIES LTD and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
